Nanjing Norman Biological Technology Co., Ltd. is a national high-tech enterprise specializing in the R&D, production, sales and service of in vitro diagnostic products. As the only member of the National Medical Clinical Laboratory and In Vitro Diagnostic System Standardization Technical Committee (TC136) in Nanjing. The company's business covers immunodiagnosis, molecular diagnosis and other fields.

Immunodiagnostic products: The Norman orbital small automatic chemiluminescence analyzers have the world's original 7-minute rapid chemiluminescence detection technology, PCT (procalcitonin) European and American patents, 10 microliter peripheral blood detection technology, and nearly 100 kinds of reagents for outpatient and emergency inflammation, chest pain, myocardial infarction, heart failure, acute abdomen, gynecological diagnosis, etc.

Molecular diagnostic products: molecular POCT products adopt advanced extraction-free technology, which can complete the detection of samples within 30 minutes.

Self-test field: Based on the innovative microfluidic molecular diagnostic technology, Norman self-test products can realize self-test of human or pet infectious diseases, such as new crown, influenza A and B, syncytial virus, rotavirus, norovirus, AIDS, syphilis, gonorrhea, etc.

Biological material field:  include antigens, antibodies, magnetic beads, key enzymes for molecular diagnosis, Taq DNA polymerase, T7 RNA polymerase, vaccinia virus capping enzyme, etc.

Covid-19: Norman now introduces Coronavirus (COVID-19, SARS-CoV-2, 2019-nCOV) Test Kits POCT Portafolio for health professional.